Zomagen Biosciences

Technologiepark 94

9052 Gent

BE

Zomagen Biosciences

Foundation date

26/02/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Zomagen is a therapeutic product discovery & development biotech company focussed on compounds targeting the innate immune system, eventually to treat diseases with chronic inflammatory involvement.

Upcoming events

Latest news

  • Tom Plitz commences role as Chief Executive Officer of Precirix

    Friday March 1st 2024

  • Newly discovered protein blocks sleeping sickness

    Wednesday February 28th 2024

  • DONESTA┬« safety study for menopause completes treatment phase and advances to data management & reporting phase

    Wednesday February 28th 2024